News
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in ...
The optic nerve carries visual information from the eye to the brain. Optic neuritis is when your optic nerve becomes inflamed, causing vision loss. Learn more.
SEVILLE, Spain — Treatment of optic neuritis with corticosteroids, findings from the Optic Neuritis Treatment Trial and the validity of previous treatment paradigms were debated at the ...
Oculis Holding has reported that the randomised Phase II Acute OptiC NeUrITis of DemYelinating Origin (ACUITY) trial of OCS-05, in treating individuals with acute optic neuritis, met the primary ...
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential ...
The trial evaluated the safety, tolerability and efficacy of OCS-05, a neuroprotective candidate, in patients with acute optic neuritis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results